Magnaspartate 243mg (magnesium 10mmol) oral powder sachets

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Magnesium aspartate

可用日期:

magnesium 10mmol) oral powder sachets (Kora Healthcare

ATC代码:

A12CC05

INN（国际名称）:

Magnesium aspartate

剂量:

243mg

药物剂型:

Powder for oral solution

给药途径:

Oral

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 09050103; GTIN: 5391500440287

产品特点

OBJECT 1
MAGNASPARTATE 243MG POWDER FOR ORAL SOLUTION
Summary of Product Characteristics Updated 13-Jun-2017 | Kora
Healthcare
1. Name of the medicinal product
Magnaspartate 243 mg powder for oral solution
2. Qualitative and quantitative composition
Each 6.5 g sachet of powder contains magnesium aspartate dihydrate
equivalent to 243 mg (10 mmol) of
magnesium.
Excipient(s) with known effect: Each sachet contains 2.706g sucrose
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Powder for oral solution
White powder with a peach/apricot-like flavour.
4. Clinical particulars
4.1 Therapeutic indications
Treatment and prevention of magnesium deficiency, as diagnosed by a
doctor.
Magnaspartate is indicated in adults, children and adolescents aged
from 2 years.
4.2 Posology and method of administration
Posology
ADULTS (> 18 YEARS)
1-2 sachets daily (243-486 mg magnesium or 10-20 mmol magnesium)
CHILDREN AND ADOLESCENTS: 10 TO 18 YEARS
1 sachet daily, (243 mg magnesium or 10 mmol magnesium)
CHILDREN: 4-10 YEARS
One level 5ml spoon daily (109 mg magnesium) or One sachet daily (243
mg magnesium).
CHILDREN: 2 TO 4 YEARS
One level 5ml spoon daily. (109 mg magnesium or 4.5mmol magnesium)
The safety and efficacy of Magnaspartate in children below 2 years has
not been established
RENAL PATIENTS:
Magnaspartate 243 mg is contraindicated in patients with severe renal
impairment (see section 4.3).
There is no dose adjustment necessary in patients with mild to
moderate renal impairment.
ELDERLY:
No dose adjustment is necessary.
Method of administration
For oral use after solution in water, tea or orange juice.
Magnaspartate can be dissolved in 50-200mL water, tea or orange juice.
Stir until the solution in water is cloudy to transparent. In orange
juice or tea inactive particles will be
visible. The solution should be taken immediately after being
prepared.
Discard any remaining content of the sachet.
_Note_
If necessary, Magnaspartate in 200ml water can be administered via a
gastric, duodenal, and nasal feeding